This page contains Plain language commissioning decisions for patient information until NICE guidance issued

BNF 11 Eye

•  Anti-vascular endothelial growth factors for the treatment of choroidal neovascularisation caused by pathological myopia
• Bevacizumab for the treatment of neovascular (wet) aged related macular degeneration

  <<<<< click this link to return to the main PHTCG - Plain language commissioning decisions page <<<<<